Registry of Vaccine Responses in Immune Compromised Patients
ConditionImmunosuppression
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorLaure Pittet, MD-PhD
About this trial
The aim of this project is to monitor, guide and document vaccination, vaccine responses, persistence of protection, vaccine efficacy and safety in immune compromised patients at various moment of their disease: right after the diagnosis, before the introduction of the immunosuppressive treatment, once the individual is under immunosuppressive treatment, or once immunosuppression is over.
Eligibility criteria
Qualifiers
Immune compromised patient or patient who will soon be immunocompromised
Informed consent as documented by signature
Disqualifiers
Individual/parental inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, known/suspected non-compliance, substance abuse, etc.
Plan to move out of the country or have prolong absence in the next 2 months
Trial design
Treatments tested in this trial
- Collection of data in a registry
Treatment groups
300 Participants
are divided into 1 treatment groupSponsors and collaborators
Laure Pittet, MD-PhD
Lead sponsor
Pediatric Clinical Research Platform
Sponsor institution
Source ClinicalTrials.gov